Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07337590 · ClinicalTrials.gov registry record · NA
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
A NA study, sponsored by Exero Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07337590: Recruiting NA study, sponsored by Exero Medical.
NCT07337590 is a NA study that is actively recruiting participants, run by Exero Medical. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07337590, a NA study, is actively recruiting participants, sponsored by Exero Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Purpose: To evaluate the effect of xBar system utilization on clinical outcomes during recovery following colorectal surgery.
Primary Outcome
Non-inferiority of the mean Modified Comprehensive Complication Index (MCCI) of the modified intent-to-treat (mITT) population at 30 days following the index surgery, compared with the MCCI of the matched historical cohort.
Interventions
- DEVICE xBar™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-03-10 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07337590 shows while recruiting
NCT07337590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which xBar™ System is the first listed.
NCT07337590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07337590 about?
NCT07337590 is a clinical study titled "Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar". Purpose: To evaluate the effect of xBar system utilization on clinical outcomes during recovery following colorectal surgery.
What is the current status of trial NCT07337590?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-03-10. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07337590?
The interventions under investigation include: xBar™ System (DEVICE).
Who is sponsoring clinical trial NCT07337590?
This trial is sponsored by Exero Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07337590's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI